VIA
TECX

Virtus Investment Advisers’s Tectonic Therapeutic TECX Stock Holding History

Virtus Investment Advisers’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Sell
10,806
-2,993
-22% -$87.9K 0.09% 324
2026
Q1 		$427K Buy
13,799
+337
+3% +$8.29K 0.12% 238
2025
Q4 		$281K Buy
13,462
+8,391
+165% +$156K 0.08% 270
2025
Q3 		$79.6K Buy
5,071
+881
+21% +$18.2K 0.02% 434
2025
Q2 		$83.3K Buy
4,190
+649
+18% +$13.2K 0.03% 410
2025
Q1 		$62.7K Buy
+3,541
New +$115K 0.02% 461

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Virtus Investment Advisers's TECX Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Tectonic Therapeutic (TECX) stake by 22% in Q2 2026, selling an estimated $87.9K and leaving 10,806 shares worth $371K. The position accounts for 0.09% of the portfolio, ranked #324.

Virtus Investment Advisers first reported a position in TECX in Q1 2025 and has held it in 6 quarters since. The position peaked at $427K in Q1 2026. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Virtus Investment Advisers held 10,806 shares of Tectonic Therapeutic worth $371K as of Q2 2026.
  • Virtus Investment Advisers sold 2,993 Tectonic Therapeutic shares in Q2 2026, an estimated $87.9K.
  • Tectonic Therapeutic made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #324 holding.
  • Virtus Investment Advisers first reported a position in Tectonic Therapeutic in Q1 2025 and has held it in 6 quarters since.
  • Virtus Investment Advisers's Tectonic Therapeutic position peaked at $427K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.